Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Clinical Trial to Evaluate the Effect of Papilozumib, an Oral Synbiotic Dietary Supplement, on Vaginal and Intestinal Microbiota in Human Papillomavirus (HPV)-Positive Women

NCT07755566 is registered in ClinicalTrials.gov with Hifas da Terra S.L. as lead sponsor.

NCT NCT07755566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07755566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Clinical Trial to Evaluate the Effect of Papilozumib, an Oral Synbiotic Dietary Supplement, on Vaginal and Intestinal Microbiota in Human Papillomavirus (HPV)-Positive Women
Lead sponsor
Hifas da Terra S.L.
Phase
Not applicable
Overall status
Completed
Start date
May 5, 2023
Completion date
May 30, 2024
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

papillomavirus infections